Literature DB >> 9062149

Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia.

C J Dunton1, K H van Hoeven, A J Kovatich, R E Oliver, R Q Scacheri, J R Cater, J A Carlson.   

Abstract

The purpose of the work was to determine the feasibility and predictive value of Ki-67 immunostaining of cervical cytology and the detection of cervical dysplasia. Air-dried cervical smears were stained with MIB-1 antibody to identify the Ki-67 antigen. Nuclear decoration in abnormal squamous nuclei determined immunoreactivity. One hundred twenty-four nonpregnant patients underwent colposcopy and directed biopsies for abnormal cytology. Sensitivity (0.89), specificity (0.65), positive predictive value (0.60), and negative predictive value (0.91) were found for Ki-67 immunostaining in detection of high-grade cervical intraepithelial neoplasia (CIN) in 124 patients and positive Ki-67 staining was a significant predictor of high-grade CIN in both univariate (odds ratio 15.5 (95% CI 5.5-43.8) and multivariable (odds ratio 21.5 (95% CI 5.0-92.0) analysis. In 101 patients with ASCUS and LGSIL, Ki-67 immunostaining demonstrated the following in detection of high-grade CIN: sensitivity (0.96), specificity (0.67), positive predictive value (0.49), and negative predictive value (0.98). Ki-67 immunostaining of cervical cytology is a predictor of significant cervical pathology with high sensitivity and negative predictive value. Ki-67 immunostaining of cervical cytology may represent a new and cost-effective triage tool for patients with minor abnormalities on cytology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062149     DOI: 10.1006/gyno.1996.4602

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.

Authors:  Arkadiusz Gertych; Anika O Joseph; Ann E Walts; Shikha Bose
Journal:  Ann Biomed Eng       Date:  2012-01-04       Impact factor: 3.934

2.  Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?

Authors:  S Sahebali; C E Depuydt; K Segers; A J Vereecken; E Van Marck; J J Bogers
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

3.  Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs.

Authors:  Charlotte A Brown; Johnannes Bogers; Shaira Sahebali; Christophe E Depuydt; Frans De Prins; Douglas P Malinowski
Journal:  J Oncol       Date:  2012-02-28       Impact factor: 4.375

4.  Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.

Authors:  Adrya Lúcia Peres; Keilla Maria Paz E Silva; Rosângela Ferreira Frade de Araújo; José Luiz de Lima Filho; Mário Ribeiro de Melo Júnior; Danyelly Bruneska Gondim Martins; Nicodemos Teles de Pontes Filho
Journal:  J Biomed Sci       Date:  2016-05-12       Impact factor: 8.410

5.  Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16INK4a Expression.

Authors:  Sayaka Kawashita; Katsuya Matsuda; Hisayoshi Kondo; Yuriko Kitajima; Yuri Hasegawa; Takako Shimada; Michio Kitajima; Kiyonori Miura; Masahiro Nakashima; Hideaki Masuzaki
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

6.  Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma.

Authors:  Yu Meng; Quan Quan; Fenfen Zhang; Yao Liu; Siling Ren; Xiaoling Mu
Journal:  Front Med (Lausanne)       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.